Clinical Trials Directory

Trials / Unknown

UnknownNCT00573573

Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
2 (estimated)
Sponsor
GAAD Medical Research Institute Inc. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A study to determine the possibility of using far infrared radiation to treat Hyperparathyroidism.

Detailed description

Overactive parathyroid glands secrete an excess of parathyroid hormones, resulting in increased levels of calcium in the blood stream, which can lead to weakening of the bones and to kidney stones. We are postulating that the non-invasive energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to stop the over secretion of the parathyroid hormones and normalize the body's metabolic functions.

Conditions

Interventions

TypeNameDescription
RADIATIONFar Infrared RadiationFar Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.

Timeline

Start date
2007-01-01
Primary completion
2009-03-01
Completion
2009-07-01
First posted
2007-12-14
Last updated
2009-03-24

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00573573. Inclusion in this directory is not an endorsement.